Prescription opioid use and changes in pain intensity in older Veterans

老年退伍军人处方阿片类药物的使用和疼痛强度的变化

• 批准号: 8529444
• 负责人: Steven K Dobscha
• 金额: $ 5.95万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-15 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8529444
• 关键词: Acute; Adverse effects; Adverse event; Age; Caring; Characteristics; Chronic; Data; Data Set; Databases; Diagnosis; Dose; Effectiveness; Elderly; Electronics; Frequencies; Geographic Locations; Healthcare; Healthcare Systems; Impaired cognition; Individual; Judgment; Longitudinal Studies; Measurable; Measures; Mental disorders; Modeling; Numeric Rating Scale; Observational Study; Opioid; Outcome; Outpatients; Pain; Pain intensity; Patients; Pattern; Pharmaceutical Preparations; Pharmacy facility; Prevalence; Psychomotor Performance; Research; Research Personnel; Risk; Safety; Sampling; Selection Bias; Severity of illness; Site; Subgroup; Survival Analysis; Techniques; Time; Treatment outcome; Veterans; Visit; Work; administrative database; chronic pain; clinical Diagnosis; cohort; demographics; design; experience; follow-up; health care service utilization; human old age (65+); improved; innovation; interest; non-cancer pain; population based; prescription opioid; routine care

DESCRIPTION (provided by applicant): The use of opioid medications to treat chronic non-cancer pain has increased markedly in recent years. However, it is unclear to what extent the use of opioids beyond acute care improves patient outcomes and which patients are most likely to benefit from opioids. The use of opioid medications in older adults has similarly increased, but there is very little empiric information available regarding the effectiveness of opioids for pain n older adults. In addition, older adults may be at greater risk for side effects and adverse events related to prescription opioids. The Department of Veterans Affairs (VA) collects pain intensity information as part of routine care; all patients are administered brief pain intensity measures at almost all outpatient visits. National level data including pain intensity scores and pharmacy information are stored in central VA administrative databases. This project responds directly to RFA-AG-12-006, "Leveraging Existing Data or Longitudinal Studies to Evaluate Safety and Effectiveness of Pharmacological Management of Chronic Pain in Older Adults (R03)," and takes advantage of a unique set of longitudinal data on pain intensity and prescription opioid use available to the researchers from national VA databases. This project extends the research teams' ongoing work examining pain-related outcomes and opioid prescribing patterns to further our understanding of opioid treatment outcomes among older adults. The specific objective of this study is to determine to what extent prescription opioids are associated with improvements in pain intensity among older adults treated in the VA healthcare system. Using a retrospective cohort design, we will examine a national sample of Veterans ages 65 years and older, who received VA care in 2010, who had moderate or greater pain intensity levels, and who had not been prescribed opioids in the prior 12 months. A subgroup of Veterans with new opioid starts will be examined for 12 months following opioid initiation. Most data will be obtained from the national VA Corporate Data Warehouse. We will conduct survival analysis using Cox regression models to identify factors associated with the main outcome, time to improvement in Numeric Rating Scale (NRS) pain intensity score. We will identify patient, medication-related, and site factors that predict time to improvement, including patient demographics and documented clinical diagnoses, opioid medication dose and frequency of use, and VA facility type and geographic region. Propensity scores will be used to adjust for measurable characteristics associated with opioid initiations, and in a secondary analysis, we will use geographic region as an instrumental variable to adjust for relationships between unmeasured disease severity and opioid initiations. Findings from this study will provide important information about the impact of prescription opioids on pain treatment outcomes in older adults. Results will be of considerable interest to Veterans, older adults with pain, and clinicians who treat chronic pain.

描述（由申请人提供）：近年来，阿片类药物治疗慢性非癌症疼痛的使用显著增加。然而，目前尚不清楚在急性护理之外使用阿片类药物在多大程度上改善了患者的预后，以及哪些患者最有可能从阿片类药物中获益。阿片类药物在老年人中的使用也同样增加， 关于阿片类药物对老年人疼痛的有效性，可获得的经验信息很少。此外，老年人可能面临与处方阿片类药物相关的副作用和不良事件的更大风险。作为常规护理的一部分，退伍军人事务部（VA）收集疼痛强度信息;所有患者均接受简短的疼痛强度测量， 几乎所有的门诊。包括疼痛强度评分和药房信息在内的国家级数据存储在VA中央管理数据库中。该项目直接响应RFA-AG-12-006“利用现有数据或纵向研究评估老年人慢性疼痛药物治疗的安全性和有效性（R 03）”，并利用一组独特的纵向数据关于疼痛强度和处方阿片类药物的使用研究人员可以从国家退伍军人管理局数据库中获得。该项目扩展了研究团队正在进行的研究疼痛相关结果和阿片类药物处方模式的工作，以进一步了解老年人的阿片类药物治疗结果。 本研究的具体目的是确定处方阿片类药物在多大程度上与VA医疗保健系统中治疗的老年人疼痛强度的改善相关。使用回顾性队列设计，我们将检查65岁及以上的退伍军人的全国样本，他们在2010年接受了VA护理，他们有中度或更高的疼痛强度水平，并且在过去12个月内没有服用阿片类药物。新阿片类药物开始的退伍军人亚组将在阿片类药物开始后接受12个月的检查。大多数数据将从国家VA公司数据仓库获得。我们将使用考克斯回归模型进行生存分析，以确定与主要结局、数字评定量表（NRS）疼痛强度评分改善时间相关的因素。我们将确定预测改善时间的患者，药物相关和现场因素，包括患者人口统计学和记录的临床诊断，阿片类药物剂量和使用频率以及VA设施类型和地理区域。倾向评分将用于调整与阿片类药物启动相关的可测量特征，在二次分析中，我们将使用地理区域作为工具变量，以调整未测量的疾病严重程度与阿片类药物启动之间的关系。这项研究的结果将提供有关 处方阿片类药物对老年人疼痛治疗结果的影响。结果将是相当感兴趣的退伍军人，老年人与疼痛，和临床医生谁治疗慢性疼痛。